| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106586 Hormone replacement therapy method and its administration form |
| 06/03/2004 | US20040106576 Derivatives of venlafaxine and methods of preparing and using the same |
| 06/03/2004 | US20040106561 comprises phytoestrogen isolated from red clover or soya, selected from genistein, daidzein, biochanin A, and/or formononetin; for treatment/prevention of cancer |
| 06/03/2004 | US20040106181 Novel isoform of human camp-dependent protein kinase, calpha -s , localizes to sperm mid-piece and the use thereof |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination |
| 06/03/2004 | US20040103902 Condom with an erectogenic composition |
| 06/03/2004 | CA2504250A1 Use of selective progesterone receptor modulators for the treatment of androgen deficiency |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423415A2 Intracellular signaling molecules |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423165A2 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 06/02/2004 | EP1423147A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423103A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP0828500B1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501935A Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 06/02/2004 | CN1501934A Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501933A Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501932A Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501929A Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1500522A Suppository for treating gynecopathy and its preparation technology |
| 06/02/2004 | CN1500516A Chinese traditional medicine composition for impotence, its preparation method and quality control method |
| 06/02/2004 | CN1500507A Compound formulation of traditional Chinese medicine for climacteric syndrome and preparation method |
| 06/02/2004 | CN1500501A Compound traditional Chinese medicine formulation for curing hysteromyoma |
| 06/02/2004 | CN1500490A Rinsing liquid for endometritis and its preparation method |
| 06/02/2004 | CN1500478A Release delayed solid oral prophylactic or pregnancy stopping pill and its use |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof |
| 06/02/2004 | CN1151792C Use of anti-oestrogens in preparation of drugs of male contraceptives |
| 06/02/2004 | CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives |
| 06/02/2004 | CN1151783C Delayed-release dosage forms of sertraline |
| 06/02/2004 | CN1151781C Use of nitric oxide donors or nitric oxide inhibitors for regulation of cervical dilatation and extensibility |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | CA2315871C Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 05/27/2004 | WO2004043994A2 A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043443A2 Drugs for sexual dysfunctions |
| 05/27/2004 | WO2004043429A1 Combination therapy for postmenopausal female sexual dysfunction comprising an androgen, and at least one agent selected from an estrogen and an anti-muscarinic |
| 05/27/2004 | WO2003045229A3 Methods and compositions for treating cancer |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102506 Pyrazole compositions useful as inhibitors of ERK |
| 05/27/2004 | US20040102479 Novel benzopyran or thiobenzopyran derivatives |
| 05/27/2004 | US20040102475 Methods for treatment of erectile dysfunction |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102429 Zinc salt compositions for the prevention of dermal and mucosal irritation |
| 05/27/2004 | US20040102426 16,17-carbocyclic condensed steroid compounds having selective estrogenic activity |
| 05/27/2004 | US20040102410 In particular, invention relates to alphavirus-based, preferably Sindbis virus-based, vectors and to non-alphavirus-based vectors, which have a preferential affinity for high affinity laminin receptors |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040101934 Beverage comprising peptide nerve growth factor conjugate for use in treatment of pain; analgesics; tranquilizers |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | US20040101579 Isoflavones and saponins in defined ratios, menopause, cancer |
| 05/27/2004 | US20040101550 Transdermal therapeutic system |
| 05/27/2004 | CA2503992A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421099A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 05/26/2004 | EP1421087A1 Diazacycloalkanes as oxytocin agonists |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421061A1 Oxime derivatives for the treatment of dyslipidemia and hypercholesteremia |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420796A1 Androgen receptor modulators and methods of use thereof |
| 05/26/2004 | EP1420795A1 As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness |
| 05/26/2004 | EP1420657A1 Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
| 05/26/2004 | EP1322315A4 Formulations for reducing or eliminating toxicity of environmental hormones containing ursodeoxycholic acid |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1250148B1 Use of fsh for treating infertility |
| 05/26/2004 | EP0971694B1 Drug preparations for treating sexual dysfunction |
| 05/26/2004 | CN2617362Y Suppository for vagina medicine feed |
| 05/26/2004 | CN1500097A Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 05/26/2004 | CN1500096A Osteoprotegerin in milk |
| 05/26/2004 | CN1499977A Compsns. and method of tissue superoxygenation |